コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 gulate MEK-1/2 and ERK-1/2 in BALB/c-derived peritoneal macrophages.
2 urvived significantly less in BALB/c-derived peritoneal macrophages.
3 osis factor-alpha from RAW 264.7 and primary peritoneal macrophages.
4 , Gata6 is expressed selectively in resident peritoneal macrophages.
5 stantial alterations in the transcriptome of peritoneal macrophages.
6 d a significant reduction in survival within peritoneal macrophages.
7 KO was required for stimulation of elicited peritoneal macrophages.
8 rophage-dense atherosclerotic lesions and in peritoneal macrophages.
9 ve microenvironment via paracrine effects on peritoneal macrophages.
10 iation, metabolism, and survival of resident peritoneal macrophages.
11 by spleen and an 85% reduction in uptake by peritoneal macrophages.
12 8.5 mug . mL(-1)) cultured in vitro in mouse peritoneal macrophages.
13 ated murine RAW264.7 macrophages, as well as peritoneal macrophages.
14 mmatory mediators in thioglycollate-elicited peritoneal macrophages.
15 ouse sera and livers, as well as in cultured peritoneal macrophages.
16 ce of palmitate on LPS-mediated responses in peritoneal macrophages.
17 asts (MEFs) and primary C/EBP-beta-deficient peritoneal macrophages.
18 lity of 0.776 in bovine MDM and 0.8 in mouse peritoneal macrophages.
19 d IL-1beta was confirmed to be attenuated in peritoneal macrophages.
20 take and trafficking in wild-derived MOLF/Ei peritoneal macrophages.
21 F4/80(+) circulating leukocytes and elicited peritoneal macrophages.
22 epithelial cells co-cultured with AEBP1(TG) peritoneal macrophages.
23 (iNOS) and S-nitrosylated in proinflammatory peritoneal macrophages.
24 lating Ly6C(high) inflammatory monocytes and peritoneal macrophages.
25 ed IL-27(p28) gene expression and release in peritoneal macrophages.
26 the inflamed peritoneum and develop into new peritoneal macrophages.
27 eukin (IL)-12 secretion response to TgPRF in peritoneal macrophages.
28 ydrolytic activity was replicated in primary peritoneal macrophages.
29 s specificity and are inactive toward murine peritoneal macrophages.
30 sis factor alpha (TNF-alpha) production from peritoneal macrophages.
31 ts were obtained for bone marrow-derived and peritoneal macrophages.
32 mediates phagocytosis of apoptotic cells by peritoneal macrophages.
33 different sizes on murine bronchoalveolar or peritoneal macrophages.
34 ns in established cells and in primary mouse peritoneal macrophages.
35 t pro-inflammatory cytokine interleukin-6 in peritoneal macrophages.
36 cription in Newcastle disease virus-infected peritoneal macrophages.
37 east tumors to identify peptides that target peritoneal macrophages.
38 hages and in vivo by thioglycolate-recruited peritoneal macrophages.
39 (keyhole limpet hemocyanin), on cultures of peritoneal macrophages.
40 induce apoptotic cell phagocytosis by murine peritoneal macrophages.
41 ecreased the uptake of spirochetes by murine peritoneal macrophages.
42 transcripts in Mecp2-deficient microglia and peritoneal macrophages.
43 of TLR pathway-specific genes compared with peritoneal macrophages.
44 alpha, although at much lower levels than in peritoneal macrophages.
45 rrow, blood, lung, and spleen, as well as in peritoneal macrophages.
46 o death and led to a contraction of resident peritoneal macrophages.
48 ats' peritoneal cavity, and their effects on peritoneal macrophages activation and in systemic inflam
51 bited and greatly impaired in the absence of peritoneal macrophages after depletion with clodronate e
52 nous transcriptional response of single-cell peritoneal macrophages after exposure to apoptotic cells
53 changes in circulating Ly6C(+) monocytes and peritoneal macrophages, along with increased CD36 expres
55 ins, but in vitro complement killing assays, peritoneal macrophage and whole blood stimulations, phag
58 roduction as well as caspase-1 activation by peritoneal macrophages and bone marrow-derived dendritic
59 nhibition of CD36 attenuated phagocytosis in peritoneal macrophages and brain M-MPhi These findings d
60 in polymerization, resulting in spreading of peritoneal macrophages and diminished uptake of E. coli.
62 XC receptor 3 (CXCR3) expression on elicited peritoneal macrophages and granulocytes increases follow
63 differentiation of human monocytes and mouse peritoneal macrophages and hematopoietic progenitor cell
65 for FR-alpha selectivity over FR-beta in rat peritoneal macrophages and human peripheral blood monocy
66 expressing ospC mutant spirochetes by murine peritoneal macrophages and human THP-1 macrophage-like c
67 egrative, and enlarged nuclear morphology of peritoneal macrophages and hyperphosphatemia were found
68 METHODS AND We quantified efferocytosis in peritoneal macrophages and in atherosclerotic lesions of
69 ression of TNFalpha and interleukin-1beta in peritoneal macrophages and increases the systemic inflam
70 varian cancer cells stimulated chemotaxis of peritoneal macrophages and induced macrophages to acquir
71 ed a significant but comparable reduction of peritoneal macrophages and lymphocytes, accompanied by a
72 DCAR was predominantly expressed in small peritoneal macrophages and monocyte-derived inflammatory
77 o suppressed the expression of iNOS in mouse peritoneal macrophages and primary human astrocytes.
78 ase in C5aR1 expression was also observed in peritoneal macrophages and several tissues from LysM-Cre
79 diaphragm tissue and in primary cultures of peritoneal macrophages and skeletal muscle fibroblasts.
81 dent chemokine production by pristane-primed peritoneal macrophages and suggest that C1q, and not C3,
82 ificantly augmented arginase-1 expression in peritoneal macrophages and SVF cells in both wild-type a
83 ne macrophages, such as primary alveolar and peritoneal macrophages and the macrophage cell line RAW2
85 equired for the homeostatic proliferation of peritoneal macrophages and their expansion during type 2
86 aride, (ii) enhancing phagocytic activity of peritoneal macrophages, and (iii) clearing bacterial per
88 including CD19(+) B cells, CD11b(+)F4/80(+) peritoneal macrophages, and CD11c(+) bone marrow-derived
90 d macrophages and in vivo by resident murine peritoneal macrophages, and diverted the anti-inflammato
92 elevates RIP140 but lowers miR-33 levels in peritoneal macrophages, and increases the production of
93 e marrow chimeric mice, adoptive transfer of peritoneal macrophages, and myeloid-specific P2X7(-/-) m
94 ed in RAW264 macrophage-like cells or murine peritoneal macrophages, and their influence on LPS-induc
95 st (IL-1Ra) secretion in LPS-activated mouse peritoneal macrophages, and this response was regulated
96 M1-polarized murine macrophages, as well as peritoneal macrophages, and was associated with increase
98 ecretion of IL-1beta, IL-6, and KC (IL-8) by peritoneal macrophages as compared with WT controls.
99 f C5a, and could be demonstrated in cultured peritoneal macrophages as well as in the setting of anti
100 mmatory macrophages (thioglycollate-elicited peritoneal macrophages) as compared with bone marrow-der
102 y, we identified a subpopulation of resident peritoneal macrophages characterized by high expression
104 0 were all significantly increased in murine peritoneal macrophages co-cultured with PbANKA-infected
105 eal exudate cells and decreased in PTEN(-/-) peritoneal macrophages compared with wild-type (WT) cell
106 z2-Cre x Gata6(flox/flox) mice, the resident peritoneal macrophage compartment, but not macrophages i
107 ase activity except in liver and in resident peritoneal macrophages, confirming endothelial specifici
108 s or knockdown of the CD36 receptor in mouse peritoneal macrophages, confirming the specific binding
109 effect of T3 is coupled to the modulation of peritoneal macrophage content, in a context not fully ex
110 ide increased liver injury and the levels of peritoneal macrophage cytokines, including IL-1beta, in
112 e marrow-derived and thioglycollate-elicited peritoneal macrophages deficient for Btk and Tec secrete
116 ver, IL-13 stimulation of alpha(M)-deficient peritoneal macrophages demonstrated an upregulated level
118 PEGs) stimulate potent cytokine responses in peritoneal macrophages, despite not being internalized.
121 vitro of C5a to lipopolysaccharide-activated peritoneal macrophages dose dependently antagonized the
122 examethasone to lipopolysaccharide-activated peritoneal macrophages dose-dependently suppressed the e
125 ects of PD-1, we found the following: first, peritoneal macrophages expressed significantly higher le
128 they appear to facilitate the activation of peritoneal macrophages (F4-80(+)GR-1(-)) and F4-80(+)Gr-
129 eeding suppressed atherosclerosis, decreased peritoneal macrophage foam cell formation, and downregul
131 espite similar clearance of apoptotic cells, peritoneal macrophages from Abca1(-/-)Abcg1(-/-), Abcg1(
135 cing, we characterized the transcriptomes of peritoneal macrophages from BALB/c and IL4Ralpha(-/-) mi
138 In contrast, a much lower percentage of peritoneal macrophages from C3(-/-) mice phagocytosed GP
140 all interfering RNA knockdown of Arg2 and in peritoneal macrophages from C57BL/6 Arg2(-/-) mice.
141 and HFE:TFR1 complex (nonfunctional TFR1) in peritoneal macrophages from C57BL/6 mice, resulting in i
145 f G2A deficiency in macrophages, we isolated peritoneal macrophages from G2A(+/+)ApoE(-/-) and G2A(-/
146 c submucosa of Gal3-deficient mice.In vitro, peritoneal macrophages from Gal3-deficient mice were ine
147 with results from gain-of-function studies, peritoneal macrophages from GX sPLA(2)-deficient mice ex
148 pt expression in tumor-associated as well as peritoneal macrophages from hrg(-/-) mice revealed an in
151 ed bactericidal NO production was reduced in peritoneal macrophages from Il10(-/-); Nod2(-/-) mice, c
152 the role of IRF-2 in apoptosis, responses of peritoneal macrophages from IRF-2(+/+) and IRF-2(-/-) mi
154 ation of anti-inflammatory genes in WAT, and peritoneal macrophages from KO mice displayed similarly
157 salpinx as severe as that of wild-type mice, peritoneal macrophages from mice deficient in TLR2 but n
158 OS and arginase-1 expression were reduced in peritoneal macrophages from mice receiving CTLA4-Ig, com
160 own-regulate PEA biosynthesis is impaired in peritoneal macrophages from mutant NAPE-PLD-deficient mi
161 umor-bearing animals express VEGFR2, whereas peritoneal macrophages from non-tumor-bearing animals do
163 of PI3K and have reduced PI3K activity, and peritoneal macrophages from PTEN(flox/flox)/LysMCre mice
175 monocyte-derived macrophage (MDM) and mouse peritoneal macrophages has been shown to be strongly ass
176 es, including murine bone marrow-derived and peritoneal macrophages, human monocyte-derived macrophag
180 a IL-1beta as well as IL-1beta production by peritoneal macrophages in a model of LPS-induced sepsis.
181 cantly higher levels of IRAK-M compared with peritoneal macrophages in a syngeneic mouse model of lun
182 (-/-) thymocytes failed to recruit wild-type peritoneal macrophages in a Transwell migration assay.
183 nes in the central clock, liver, thymus, and peritoneal macrophages in mice after chronic jet lag.
184 hat IL-4 activation of different lineages of peritoneal macrophages in mice is accompanied by lineage
186 ion of coagulation factor V (FV) by resident peritoneal macrophages in mice promotes bacterial cleara
190 bone marrow cells and reduced the number of peritoneal macrophages in wild-type mice but not EP2(-/-
191 gnificantly decreased phagocytic activity of peritoneal macrophages in WT (by 30%), but not in CD14(-
192 line RAW 264.7, and fresh amniotic fluid and peritoneal macrophages, including macrophages from TLR4
193 killing of Escherichia coli by monocytes and peritoneal macrophages incubated with lipopolysaccharide
194 naturally occurring mutation (med) in mouse peritoneal macrophages inhibited podosome formation.
195 atosis, but the mechanisms that induce naive peritoneal macrophages into TAMs are poorly understood.
196 s following cecal ligation and puncture, and peritoneal macrophage isolated from TK-/- mice exhibited
200 64.7 mouse macrophages as well as in primary peritoneal macrophages isolated from both C3H/HeJ (TLR4-
203 ased in both LPS-treated RAW 264.7 cells and peritoneal macrophages isolated from LPS-challenged mice
207 Cytokine analysis was performed on infected peritoneal macrophages isolated from these mice, and imm
208 or the self-renewal and maintenance of large peritoneal macrophages (LPMs), but not that of other tis
209 bolism were evaluated in nonactivated murine peritoneal macrophages (MPhi0) and macrophages stimulate
212 ursors, and also the numbers of the resident peritoneal macrophages, observations consistent with CSF
216 mRNA levels were significantly higher in the peritoneal macrophages of the HIV-1Tg rat than those in
217 howed a diminished capacity to infect murine peritoneal macrophages, only the Deltaasl null mutant wa
218 ar cAMP in AMs, but this was not observed in peritoneal macrophages or elicited peritoneal neutrophil
219 L-12p40 production by thioglycolate-elicited peritoneal macrophages or GM-CSF plus IL-4-induced bone
223 LPS-induced TNF-alpha production by resident peritoneal macrophages (PerMphi) in type 2 diabetic (db/
224 ulated platelets also significantly enhanced peritoneal macrophage phagocytosis of both methicillin-r
225 or M2 activation of RAW264.7 macrophages and peritoneal macrophages (PM) on subsequent HSV-1 infectio
226 sion of alphavbeta3, but primary cultures of peritoneal macrophages (PMo) required activation of TLR4
227 USP21 also restricted antiviral responses in peritoneal macrophages (PMs) and bone marrow-derived den
229 nvestigated the functions and origins of two peritoneal macrophage populations in mice: small and lar
230 5-HT transporter inhibited 5-HT uptake into peritoneal macrophages, prevented 5-HT-induced phosphory
232 SMase-deficient (asm(-/-)) mice and isolated peritoneal macrophages produce severalfold more TNFalpha
234 ta6 deficiency also resulted in dysregulated peritoneal macrophage proliferative renewal during homeo
237 In vivo, amlodipine and verapamil suppressed peritoneal macrophage recruitment in response to thiogly
239 those in the infected mice, and depletion of peritoneal macrophages rendered the mice significantly m
243 THP-1 cells, and genetic deletion of RAGE in peritoneal macrophages, revealed that hypoxia-induced up
247 more, C1q-deficient pristane-primed resident peritoneal macrophages secreted significantly less CCL3,
250 19 compared with WT mice, and RELMalpha(-/-) peritoneal macrophages showed deficient IL-23p19 inducti
251 accharide-stimulated thioglycollate-elicited peritoneal macrophages showed increased inflammatory gen
252 , expression arrays conducted on HRG-treated peritoneal macrophages showed induction of genes involve
253 sed on studies in which (i) biotinylation of peritoneal macrophages showed that endogenous ABCG1 is i
255 e, investigation of the activation status of peritoneal macrophages showed that the expression of gen
256 d higher survival within the THP-1 and mouse peritoneal macrophages, simultaneously increasing the in
257 rophage populations in mice: small and large peritoneal macrophages (SPM and LPM, respectively).
258 lective mobilization of unconventional small peritoneal macrophages (SPMs) that, in comparison with l
260 ofiling microarray analysis in primary mouse peritoneal macrophages stimulated with LXR ligands.
261 rain mononuclear cells, blood monocytes, and peritoneal macrophages, suggesting that cell surface CD3
266 tion and resulted in increased cAMP level in peritoneal macrophages through G protein-coupled E-serie
267 localization and functional polarization of peritoneal macrophages through the reversible induction
268 nt with the expression of these receptors in peritoneal macrophages (TLR2/4, C5aR) and mesothelial ce
269 consistent with that of GPCR, allowing mouse peritoneal macrophages to migrate toward its ligand CCL5
270 m the Golgi and recycling endosomes of mouse peritoneal macrophages to newly formed phagosomes and re
271 genes were specifically modified by exposing peritoneal macrophages to PS or PC liposomes in vivo.
273 equired for bone marrow macrophages, but not peritoneal macrophages, to phagocytose apoptotic neutrop
274 Gata6 in the macrophage compartment affected peritoneal macrophages, using Lyz2-Cre x Gata6(flox/flox
275 p. injection, percent phagocytosis of GPs by peritoneal macrophages was comparable in wild-type and D
276 lyso-PS(high) neutrophils (95% viable) by WT peritoneal macrophages was quantitatively similar to UV-
277 oneally with dl922-947 and beta3 null murine peritoneal macrophages, we confirm a role for macrophage
279 Ex vivo stimulation studies using murine peritoneal macrophages were also used to elucidate the p
280 rophage-like RAW264.2 cells or mouse primary peritoneal macrophages were challenged with nicotine; an
282 opment of cellular dysfunction; second, when peritoneal macrophages were depleted (using clodronate l
287 phages (SPMs) that, in comparison with large peritoneal macrophages, were enriched for IL-17 receptor
288 urthermore, we showed that Arhgef1-deficient peritoneal macrophages when either injected into the lun
289 of cytosolic phospholipase A(2) in resident peritoneal macrophages, which are specifically primed fo
290 on causes a decrease in the thiol content of peritoneal macrophages, which can influence IL-12 produc
292 ed by in vitro studies in which treatment of peritoneal macrophages with a nuclear factor-kappaB inhi
293 macrophages and correlated FoxO1 activity in peritoneal macrophages with IL-1beta production profiles
294 stimulation of murine bone marrow-derived or peritoneal macrophages with IL-33 failed to promote argi
295 n this model in that in vitro stimulation of peritoneal macrophages with killed LAC-4 induced a simil
299 dies demonstrate that stimulation of primary peritoneal macrophages with macrophage-stimulating prote
300 cholesterol crystal-activated cultured mouse peritoneal macrophages, with a maximum effect at approxi